Work

Reduced humoral immune response after mRNA vaccination correlates with breakthrough SARS-CoV-2 infection in ocrelizumab-treated multiple sclerosis patients (P12-3.005)

Year: 2023

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000203830

Authors: Frederik Novak, Hamza Bajwa, John Eugenio Coia, Anna Christine Nilsson, Christian Nielsen, Dorte Holm, Kamilla Østergaard, Mathilde Hvidt, Keld-Erik Byg, Isik Johansen, Kristen Mittl, William Rowles, Scott Zamvil, Riley Bove, Joseph Sabatino, Tobias Sejbaek

Institutions: Hospital South West Jutland, University of Southern Denmark, Nordsjællands Hospital, Regional Hospital Central Jutland, Odense University Hospital, University of California, San Francisco

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367296438

FWCI:

Cites:

Cited by:

Related to: 10